Dr. Thomas E. Stinchcombe is a medical oncologist at the Duke Cancer Institute and a Professor of Medicine at the Duke School of Medicine in Durham, North Carolina. He specializes in the treatment of thoracic malignancies, including small and non-small cell lung cancer and malignant pleural mesothelioma. Dr. Stinchcombe is actively involved in the development
Dr. Ramesh Rengan is a radiation oncologist at the University of Washington and Fred Hutch Cancer Center. He specializes in radiation treatment of lung cancer and thoracic malignancies including pleural mesothelioma, as well as melanoma, ocular tumors, renal cell carcinoma, and prostate cancer. In addition to treating patients using innovative radiation tools, Dr. Rengan oversees
Dr. Craig Stevens is a radiation oncologist specializing in treating patients with lung cancer and malignant pleural mesothelioma at Beaumont Health in Royal Oaks, Michigan (now known as Corewell Health). He holds the title of System Chair of Radiation Oncology for Beaumont Health, as well as Department Chair and Professor of Radiation Oncology at Oakland
Dr. Konstantinos Arnaoutakis is a medical oncologist at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences, where he specializes in the care of patients diagnosed with lung cancer and malignant pleural mesothelioma. In treating patients diagnosed with thoracic and other malignancies, Dr. Arnaoutakis relies on traditional treatments including chemotherapy,
Dr. Robert Ramirez is a medical oncologist specializing in treating thoracic and neuroendocrine malignancies at Vanderbilt University Medical Center in Nashville, Tennessee. As a member of the Division of Hematology and Oncology, his focus is on neuroendocrine tumors, lung cancers, and other thoracic malignancies. Dr. Ramirez is helping to expand Vanderbilt University’s established NET program
Dr. Batus is a medical oncologist at Rush University in Chicago, Illinois. Her practice largely consists of caring for patients diagnosed with all types of lung cancer, sarcoma, and melanoma. She works as part of a multidisciplinary team, creating the right treatment plan for each patient based on their condition and their individual goals. Treatment plans
Dr. Daniel Miller is a thoracic surgeon and oncologist at Augusta University’s Georgia Cancer Center. He is considered a world leader and pioneer in the use of minimally invasive procedures for the treatment of thoracic malignancies including malignant pleural mesothelioma and lung cancer and benign thoracic diseases. Dr. Miller’s clinical interests include lung cancer, mesothelioma,
Dr. James D. Maloney is a general thoracic and oncologic surgeon who specializes in the treatment of lung cancer at the University of Wisconsin in Madison, Wisconsin. Dr. Maloney’s skills include minimally invasive surgical techniques, including thoracoscopic lobectomy, lung volume reduction surgery, bronchoscopy, thoracentesis, and video-assisted thoracoscopy (VATS). He also performs lung transplants. Dr. Maloney
Dr. Malcolm DeCamp is the K. Craig Kent Chair in Strategic Leadership and Professor of Surgery and Chair of the Division of Cardiothoracic Surgery at the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin. A cardiothoracic oncologic surgeon, he focuses his considerable expertise and skill on thoracic oncology and the care
Biotechnology company RS Oncology has announced the start of a new Phase 2 clinical study of its drug, RSO-021 for the treatment of malignant pleural mesothelioma and other thoracic malignancies, and the successful first dosing of a patient. The multicenter study based in the United Kingdom is evaluating the drug’s impact on patients suffering the